We report an extreme low birth weight infant with gastrointestinal mucormycosis (GM) mimicking necrotizing enterocolitis on day 15 of age. Emergency laparotomy confirmed ileal perforations. Subsequently, tissue histology confirmed GM. This is the most premature infant who survived after GM and is the third reported neonatal survivor in English literature.
INTRODUCTION
Intestinal perforation in extreme low birth weight (ELBW) babies is not uncommon. Common causes include bowel perforation in necrotizing enterocolitis (NEC), indomethacin treatment for patent ductus arteriosus 1 and dexamethasone treatment for bronchopulmonary dysplasia. 2 Occasionally, it can be spontaneous. 3 We report a case of intestinal perforation in an ELBW infant as a result of gastrointestinal mucormycosis (GM).
CASE REPORT
A male ELBW infant was delivered by emergency Caesarean section at maturity of 26 week and 4 days because of placenta previa type III with antepartum haemorrhage and prolonged rupture of membrane. He was the second of a set of triplets conceived by in vitro fertilization. A course of antenatal dexamethasone was given prior to delivery. Apgar score was 2 and 7 at first and fifth minutes, and his birth weight was 839 g. Maternal high vaginal secretion for culture was negative.
He developed hyaline membrane disease at birth and was treated with three doses of intratracheal surfactant. He developed symptomatic patent ductus arterisous on day 8 and was treated with intravenous indomethacin, which was stopped on day 11 when thrombocytopenia and raised serum creatinine appeared.
Intravenous dexamethasone was started on day 12 for evolving bronchopulmonary dysplasia, which was stopped on day 15 when NEC was suspected. He was given intravenous penicillin and aztreonam when he had respiratory distress during the first 4 days and was switched to intravenous vancomycin and ceftazidime on day 9 because of unstable temperature. Blood cultures prior to systemic antibiotics were negative. Both umbilical artery and vein were catheterized on day 1 and were in situ. He deteriorated suddenly on day 15 with abdominal distension. There was bluish discoloration of the abdominal wall and bowel sounds were sluggish. He was on minimal enteral nutrition with expressed breast milk via oro-gastric tube and parenteral nutrition; feeding was tolerated and bowel motion had been normal before deterioration. Laboratory tests at time of deterioration were as follows: CBC: Hgb: 14.9 g/dl, WBC: 41.4 Â 10 9 /l, platelet: 99 Â 10 9 / l; arterial blood gas: pH: 7.27, PaCO 2 : 5.62 kPa, PaO 2 : 16.2 kPa, base excess: À6.8 mmol/l. Abdominal X-rays showed gas in scrotum, but without other features of pneumoperitoneum ( Figure 1 ). NEC was suspected, therefore umbilical catheters were removed and intravenous metronidazole, vancomycin and amikacin were started. Emergency laparotomy was performed, two small perforations at the distal ileum without bowel gangrene were found. A length of 4 cm of ileum were resected and ileostomy was fashioned. Microscopic examination showed that most of the small intestine mucosa was viable with congestion and haemorrhage in the lamina propria. The small bowel wall, especially the tissue around the site of perforation demonstrated significant tissue infiltration by fungal organism. This fungal organism demonstrated irregular branching, but nonseptated appearance and vascular invasion of intestinal blood vessel lumen by fungal hyphae was also evident (Figure 2a, b) . Bacterial and fungal cultures on blood, peritoneal fluid, and cerebrospinal fluid were negative. Thus, diagnosis of GM was made based on these histological findings. Intravenous amphotericin B was commenced on postoperative day 3 when the histological findings were made, and total 6 weeks of amphotericin B was given. He was complicated by high ileostomy output, which caused malnutrition. Eventually, ileostomy was closed at 4 months of age. He retained full enteral feeding after gut anastomosis and was discharged home with satisfactory weight gain.
DISCUSSION
Mucormycoses are ubiquitous saprophytic fungi, which seldom infect healthy persons. Children at risk are those who are immunocompromised, malnourished, on steroid therapy, or having diseases such as diabetes mellitus, leukaemia, and aplastic anaemia. 4, 5 Infection is acquired when fungal spores are inoculated, inhaled or ingested, and sites of infection depend on the route through which these fungal spores are contracted. Diagnosis is established by showing characteristic broad, branching and nonseptated hyphae in the fresh infected tissues; 6 tissue vascular thrombosis and infarction are hallmarks of mucormycosis infection. 7 Antigen detection is possible but with low sensitivity and specificity. 4 Culture is required to identify different species of Mucorales. Mucormycosis infection is associated with high mortality. Prompt tissue diagnosis, surgical debridement, and amphotericin B treatment are important for better survival. Rifampicin has been shown to enhance fungal killing activity of amphotericin B. 8 ELBW babies are at risk of mucormycosis infection if exposed to Mucorales. The speculations are as follows: they have immature immune system; they require lengthy neonatal intensive care; they have fragile skin barrier and are nursed in environment of high ambient humidity around 85%, which may enhance growth of and exposure to Mucorales; they receive broad-spectrum intravenous antibiotics, which affect healthy gastrointestinal flora; and they are given steroid to assist weaning off ventilator.Interventions such as oro-gastric tube placement, endotracheal intubation, and indomethacin therapy are speculated to increase risk of contracting gastrointestinal mucormycosis by causing mucosal injury. 9 Our case had all these risk factors at time of presentation. GM in neonates is very rare. 9 However, the incidence of neonatal GM might be underestimated as not all ill neonates who survived or died of the disease had detailed histological examination. Only two neonates survived after GM was reported. 7, 10 The first infant reported by Michalak was a 32-week gestation infant with hyaline membrane disease presenting with abdominal distension, stomach perforations, and gangrenous appendix; the second infant reported by Kecskes was a 29-week gestation infant with hyaline membrane disease presenting with abdominal distension and gangrenous colon. Both cases were diagnosed by tissue histology, and survived after gut resection and amphotericin B treatment. We believe our case is the most premature infant who survived after neonatal GM and is the third reported neonatal survivor in English literature. All these three survivors presented with abdominal distension mimicking NEC. Bowel gangrene was evident in the previous two survivors, but was not seen in our case. Therefore, it seems that our case was at an early stage of infection so that he responded to surgery even though amphotericin B was given on the third postoperative day. At least 13 premature infants with GM had been reported. 9 In all, 12 of 13 presented with features of NEC (abdominal distension: 12/13 (92%); haematochezia: 6/13 (46%); pneumoperitoneum: 6/13 (46%); abdominal mass with pneumatosis coli: 3/13 (23%)). In all cases, the diagnoses were made at postmorteum or by laparotomy tissue specimens. The overall survival rate was 3/13 (23%).
Clinically, it is difficult to differentiate ELBW babies with GM from NEC. Moreover, it was also reported that NEC might be followed by GM. 11 Therefore, GM should be considered as a differential diagnosis in premature infants suffering from gastrointestinal perforation or NEC. In addition, bowel gangrene might be absent in early stage of GM as illustrated in our case. This highlights the importance that all neonates with bowel surgery for inflammatory or perforating lesions should have careful tissue histological examination, and fresh specimens sent for culture in order to confirm GM. Sometimes, ELBW babies with suspected NEC are too ill for laparotomy and peritoneal drains are inserted. 12 Then, atypical causes like GM might be missed in these cases because no tissue is available for histology and the yield from peritoneal fluid culture is low. Therefore, we suggest starting parenteral amphotericin B pre-emptively for premature infants who suffer clinical NEC and fail medical treatment or for those who fail peritoneal drainage until pathological diagnosis is available. In addition, timely use of parenteral amphotericin B might reduce the hidden mortality in surgically treated NEC as a result of fungal sepsis. 13 
